National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Sebelipase alfa is indicated for long-term enzyme replacement therapy (ERT) in patients of all ages with lysosomal acid lipase (LAL) deficiency.

NCPE Assessment Process Complete
Rapid review received  08/02/2017
Rapid review completed  13/03/2017
Rapid Review outcome A Full pharmacoeconomic assessment is recommended
Full pharmacoeconomic assessment commissioned by HSE  30/03/2017
Pre-submission consultation with Applicant  22/08/2017
Submission received from Applicant  13/11/2017
Preliminary review sent to Applicant 16/03/2018
NCPE assessment re-commenced 11/04/2018
Factual accuracy sent to applicant 17/05/2018
Current Status Awaiting applicant response